潜极追踪和再进入 (STAR) 技术和潜极斑块修饰 (SPM) 的临床应用
Bryan Kindya1, Jarrod D Frizzell2, J Aaron Grantham3
1Emory University School of Medicine, Atlanta, GA, USA.
Interventional cardiology clinics
|November 23, 2025
概括
亚极端追踪和再进入 (STR) 和亚极端斑块修饰 (SPM) 为挑战慢性全封闭 (CTO) 穿皮冠状动脉干预 (PCI) 提供了解决方案. 本综述详细介绍了STR和SPM技术及其改善PCI成功率的结果.
科学领域:
- 干预心脏病学 干预心脏病学
- 血管生物学 血管生物学
背景情况:
- 慢性全封闭 (CTO) 皮肤冠状动脉干预 (PCI) 的成功率在经验丰富的中心也在85%到90%之间.
- 低极度跟踪和重新进入 (STR) 和低极度斑块修饰 (SPM) 是复杂的CTO病例的新兴技术.
研究的目的:
- 对 CTO PCI 的 STR 和 SPM 技术进行审查.
- 讨论这些干预程序的结果和最佳管理策略.
主要方法:
- 审查关于STR和SPM技术的当前文献.
- 对STR和SPM的程序成功率和并发症数据的分析.
主要成果:
- STR显示出高成功率,并发症概况较低.
- 在STR中进行气球血管整形和支架植入的最佳时间仍在调查中.
结论:
- STR和SPM是改善CTO PCI结果的有价值的辅助工具.
- 需要进一步的研究来完善气球血管整形和STR手术中的支架管理协议.
更多相关视频
09:46Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Published on: September 14, 2009
14.3K
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
1.9K
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301